Login | Users Online: 2156  
Home Print this page Email this page Small font sizeDefault font sizeIncrease font size   
Home | About us | Editorial board | Search | Ahead of print | Current Issue | Archives | Submit article | Instructions | Subscribe | Advertise | Contact us
Year : 2001  |  Volume : 2  |  Issue : 2  |  Page : 57-62

Hypertension in renal transplant recipients

Consultant Nephrologist, Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar

Correspondence Address:
Omar Abboud
Hamad Medical Corporation, P.O. Box 3050, Doha
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

The prevalence of hypertension in patients with end-stage renal disease ranges between 10 and 100%[1]. It occurs in renal transplant recipients in 40 – 75%[3],[4]. Factors contributing to post-transplant hypertension include immunosuppressive therapy: corticosteroids and calcineurin inhibitors; causes related to the graft: chronic graft dysfunction, genetic, renal artery stenosis, recurrence of the original disease and factors related to the native kidneys. Investigation of post-transplant hypertension should be directed to these possible underlying factors. Treatment considerations will depend on the presence or absence of underlying factors and should observe interaction between hypotensive medications and immunosuppressive drugs.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded65    
    Comments [Add]    

Recommend this journal